Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of A
Will GILD's Move to Acquire ACLX Boost Its Cell Therapy Franchise?
11:11am, Friday, 13'th Mar 2026
Gilead plans a $7.8B Arcellx acquisition as cell therapy sales decline, seeking full control of anito-cel to strengthen its oncology pipeline.
The Zacks Analyst Blog Oracle, T-Mobile, Gilead, and C&F Financial
04:31am, Friday, 13'th Mar 2026
Oracle's AI-driven cloud surge, T-Mobile's 5G edge, and Gilead's dominant HIV franchise headline today's top analyst reports and highlight key growth drivers.
Josh Brown: Biotech growth stocks immune to disruption risk
12:37pm, Wednesday, 11'th Mar 2026
Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC's Halftime Report this week about large-cap biotech: “These are growth stocks where you don't have to worry about disrupti
Gilead Sciences, Inc. (GILD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
12:32pm, Wednesday, 11'th Mar 2026
Gilead Sciences, Inc. (GILD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
2 Recession-Resistant Dividend Stocks to Buy Now
06:00am, Wednesday, 11'th Mar 2026
These two healthcare leaders have businesses built to withstand economic downturns. Both have grown their dividends at a pretty good clip over the past decade.
Gilead Sciences, Inc. (GILD) Presents at Leerink Global Healthcare Conference 2026 Transcript
01:50pm, Tuesday, 10'th Mar 2026
Gilead Sciences, Inc. (GILD) Presents at Leerink Global Healthcare Conference 2026 Transcript
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
10:38am, Tuesday, 10'th Mar 2026
Wall Street is drawing fresh lines across the large-cap biopharma landscape. Jefferies initiated coverage on Gilead Sciences Inc.
Pre-Market Stock Futures: Futures are trading lower as many across Wall Street breathed a semi-sigh of relief yesterday after oil futures, which shot up to $120 overnight, retreated below $100 on Mond
Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know
06:50pm, Monday, 09'th Mar 2026
Gilead Sciences (GILD) reached $146.63 at the closing of the latest trading day, reflecting a +1.88% change compared to its last close.
3 Blue-Chip Stocks Built for a Rotating Market
12:35pm, Sunday, 08'th Mar 2026
Sector rotation is a common occurrence in which investors move money out of market sectors that look overbought and into ones that seem undervalued. In 2026, that means rotating away from mega-cap tec
Gilead Sciences, Inc. $GILD Shares Sold by Blair William & Co. IL
04:35am, Sunday, 08'th Mar 2026
Blair William and Co. IL reduced its position in Gilead Sciences, Inc. (NASDAQ: GILD) by 2.3% in the undefined quarter, according to its most recent filing with the SEC. The firm owned 377,364 shares
Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term
10:41am, Friday, 06'th Mar 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
These 3 Cash Flow Machines Provide Stability in Uncertain Markets
08:26am, Friday, 06'th Mar 2026
When times get tough for companies, cash flow is an essential element that can determine viability through a challenging market. Simply put, if a firm does not have the ability to meet its near-term o
Gilead Sciences, Inc. $GILD Shares Bought by Fisher Asset Management LLC
03:58am, Friday, 06'th Mar 2026
Fisher Asset Management LLC lifted its position in shares of Gilead Sciences, Inc. (NASDAQ: GILD) by 143.5% during the third quarter, according to its most recent 13F filing with the Securities and Ex
